Literature DB >> 20840258

Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study.

Eran Hadar1, Moshe Hod.   

Abstract

The current diagnostic criteria for gestational diabetes mellitus are controversial because they lack correlation to maternal and perinatal outcome. The results of the hyperglycemia and adverse pregnancy outcome (HAPO) study demonstrate a linear association between increasing levels of fasting, 1- and 2-h plasma glucose post a 75 g oral glucose tolerance test to several significant outcome endpoints, such as birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, primary cesarean delivery, clinical neonatal hypoglycemia, premature delivery, shoulder dystocia or birth injury, intensive neonatal care admission, hyperbilirubinemia, and preeclampsia. A consensus report by the IADPSG, based on a vigorous assessment of the HAPO results and other studies, recommended an endorsement of risk-based, internationally accepted criteria for the diagnosis and classification of diabetes in pregnancy. This review follows the steps from defining the problem to the endpoint of achieving a worldwide policy change.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20840258     DOI: 10.1111/j.1749-6632.2010.05671.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Screening tests during prenatal care: does practice follow the evidence?

Authors:  Juned Siddique; John D Lantos; Tyler J VanderWeele; Diane S Lauderdale
Journal:  Matern Child Health J       Date:  2010-11-28

2.  Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

Authors:  Brian M Casey; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Patrick Catalano; Margaret Harper; George Saade; Yoram Sorokin; Alan M Peaceman
Journal:  Am J Perinatol       Date:  2014-05-16       Impact factor: 1.862

3.  New guidelines for diagnosis of gestational diabetes: pathology-based impact assessment.

Authors:  Ezekiel Uba Nwose; Ross Stuart Richards; Phillip Taderera Bwititi; Eugene George Butkowski
Journal:  N Am J Med Sci       Date:  2013-03

4.  N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial.

Authors:  Martin Andreas; Harald Zeisler; Ammon Handisurya; Maximilian B Franz; Michael Gottsauner-Wolf; Michael Wolzt; Alexandra Kautzky-Willer
Journal:  Cardiovasc Diabetol       Date:  2011-04-13       Impact factor: 9.951

5.  Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Authors:  Helen L Barrett; Kathryn L Gatford; Candice M Houda; Miles J De Blasio; H David McIntyre; Leonie K Callaway; Marloes Dekker Nitert; Suzette Coat; Julie A Owens; William M Hague; Janet A Rowan
Journal:  Diabetes Care       Date:  2012-10-09       Impact factor: 19.112

6.  SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women.

Authors:  Marloes Dekker Nitert; Helen L Barrett; Katie Foxcroft; Anne Tremellen; Shelley Wilkinson; Barbara Lingwood; Jacinta M Tobin; Chris McSweeney; Peter O'Rourke; H David McIntyre; Leonie K Callaway
Journal:  BMC Pregnancy Childbirth       Date:  2013-02-25       Impact factor: 3.007

7.  Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.

Authors:  Rebecca J Griffith; Jane Alsweiler; Abigail E Moore; Stephen Brown; Philippa Middleton; Emily Shepherd; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2020-06-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.